Iron-chelating effect of silymarin in patients with β-thalassemia major: A crossover randomised control trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Iron-chelating effect of silymarin in patients with β-thalassemia major: A crossover randomised control trial
Authors
Keywords
-
Journal
PHYTOTHERAPY RESEARCH
Volume 32, Issue 3, Pages 496-503
Publisher
Wiley
Online
2017-12-13
DOI
10.1002/ptr.5995
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation of Pancreatic Iron Overload Measured by T2*-Weighted Magnetic Resonance Imaging in Diabetic Patients with β-Thalassemia Major
- (2017) Mehrnoush Kosaryan et al. HEMOGLOBIN
- Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
- (2017) Sepideh Elyasi et al. PHYTOTHERAPY RESEARCH
- Effects of Silymarin on Diabetes Mellitus Complications: A Review
- (2017) Aline Maria Stolf et al. PHYTOTHERAPY RESEARCH
- Effect of Oral Silymarin Administration on Prevention of Radiotherapy Induced Mucositis: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
- (2016) Sepideh Elyasi et al. PHYTOTHERAPY RESEARCH
- Evaluating the Safety and Efficacy of Silymarin inβ-Thalassemia Patients: A Review
- (2015) Behjat Al-Sadat Moayedi Esfahani et al. HEMOGLOBIN
- Serum levels of TGFβ, IL-10, IL-17, and IL-23 cytokines in β-thalassemia major patients: the impact of silymarin therapy
- (2014) Sima Balouchi et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Silymarin's Protective Effects and Possible Mechanisms on Alcoholic Fatty Liver for Rats
- (2013) Wei Zhang et al. Biomolecules & Therapeutics
- Neuroprotective Potential of Silymarin against CNS Disorders: Insight into the Pathways and Molecular Mechanisms of Action
- (2013) Anupom Borah et al. CNS Neuroscience & Therapeutics
- Biosafety and antioxidant effects of a beverage containing silymarin and arginine. A pilot, human intervention cross-over trial
- (2013) Kateřina Valentová et al. FOOD AND CHEMICAL TOXICOLOGY
- THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
- (2013) Adel Abd elhaleim Hagag Mediterranean Journal of Hematology and Infectious Diseases
- A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine
- (2012) Behjat Moayedi et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Hepatoprotective and antiviral functions of silymarin components in hepatitis C virus infection
- (2012) Stephen J. Polyak et al. HEPATOLOGY
- Comparative Effects of Silymarin and Vitamin E Supplementation on Oxidative Stress Markers, and Hemoglobin Levels Among Patients on Hemodialysis
- (2011) Jamshid Roozbeh et al. RENAL FAILURE
- The iron-chelating potential of silybin in patients with hereditary haemochromatosis
- (2010) C Hutchinson et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Milk thistle in liver diseases: past, present, future
- (2010) Ludovico Abenavoli et al. PHYTOTHERAPY RESEARCH
- Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage
- (2009) E. Shaker et al. FOOD AND CHEMICAL TOXICOLOGY
- Combined therapy of silymarin and desferrioxamine in patients with β-thalassemia major: a randomized double-blind clinical trial
- (2009) Marjan Gharagozloo et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: A comparison with desferrioxamine
- (2008) Marjan Gharagozloo et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Silybin Treatment is Associated With Reduction in Serum Ferritin in Patients With Chronic Hepatitis C
- (2008) Julie M. Bares et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started